Business | Namrata Brar | Wednesday April 3, 2013
While India celebrates the Novartis ruling, the United States is condemning it. The US provides nearly 50 per cent of the profits to big pharma and India's bold decision has sent alarm waves in the lobbyist circles.
www.ndtv.com/business